Victory Capital Management Inc. boosted its position in shares of Healthequity Inc (NASDAQ:HQY) by 9.1% in the third quarter, Holdings Channel reports. The firm owned 724,729 shares of the company’s stock after purchasing an additional 60,669 shares during the period. Victory Capital Management Inc.’s holdings in Healthequity were worth $68,422,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HQY. BlackRock Inc. raised its holdings in Healthequity by 11.3% during the second quarter. BlackRock Inc. now owns 7,688,768 shares of the company’s stock valued at $577,427,000 after buying an additional 777,915 shares in the last quarter. FMR LLC raised its holdings in Healthequity by 26.5% during the second quarter. FMR LLC now owns 3,410,542 shares of the company’s stock valued at $256,132,000 after buying an additional 715,441 shares in the last quarter. Carillon Tower Advisers Inc. raised its holdings in Healthequity by 751.9% during the second quarter. Carillon Tower Advisers Inc. now owns 752,482 shares of the company’s stock valued at $56,511,000 after buying an additional 664,157 shares in the last quarter. United Services Automobile Association raised its holdings in Healthequity by 3,569.2% during the second quarter. United Services Automobile Association now owns 284,360 shares of the company’s stock valued at $4,558,000 after buying an additional 276,610 shares in the last quarter. Finally, Jennison Associates LLC raised its holdings in Healthequity by 122.8% during the second quarter. Jennison Associates LLC now owns 321,703 shares of the company’s stock valued at $24,160,000 after buying an additional 177,312 shares in the last quarter. 97.07% of the stock is owned by hedge funds and other institutional investors.
Shares of HQY opened at $95.44 on Tuesday. Healthequity Inc has a 12-month low of $42.92 and a 12-month high of $99.99. The stock has a market cap of $5.83 billion, a P/E ratio of 176.74, a PEG ratio of 3.26 and a beta of 1.39.
Healthequity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 4th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.12. Healthequity had a return on equity of 12.58% and a net margin of 23.81%. The firm had revenue of $71.10 million for the quarter, compared to analyst estimates of $69.84 million. During the same period in the previous year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 25.0% compared to the same quarter last year. On average, equities analysts anticipate that Healthequity Inc will post 0.87 EPS for the current fiscal year.
HQY has been the topic of a number of recent analyst reports. Zacks Investment Research lowered Healthequity from a “hold” rating to a “sell” rating in a research note on Wednesday, July 11th. KeyCorp lifted their price objective on Healthequity from $82.00 to $90.00 and gave the stock a “buy” rating in a research note on Thursday, July 19th. Citigroup reiterated a “buy” rating and issued a $110.00 price objective on shares of Healthequity in a research note on Wednesday, September 5th. Wells Fargo & Co lifted their price objective on Healthequity from $84.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 5th. Finally, Cantor Fitzgerald lifted their price objective on Healthequity from $68.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 5th. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. Healthequity currently has an average rating of “Buy” and a consensus target price of $93.08.
In related news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction dated Monday, August 20th. The stock was sold at an average price of $86.37, for a total transaction of $345,480.00. Following the transaction, the vice president now directly owns 99,200 shares in the company, valued at $8,567,904. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 12,000 shares of company stock worth $1,065,240 over the last 90 days. Corporate insiders own 4.00% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/11/06/victory-capital-management-inc-grows-position-in-healthequity-inc-hqy.html.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Story: Google Finance Portfolio Tips and Tricks
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.